Compile Data Set for Download or QSAR
Found 89 Enz. Inhib. hit(s) with all data for entry = 50041817
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416285(CHEMBL1171008)copy SMILEScopy InChI
Affinity DataKi:  1.26nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416284(CHEMBL1170828)copy SMILEScopy InChI
Affinity DataKi:  1.58nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416308(CHEMBL1170827)copy SMILEScopy InChI
Affinity DataKi:  2nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416304(CHEMBL1171786)copy SMILEScopy InChI
Affinity DataKi:  3.16nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416283(CHEMBL1170829)copy SMILEScopy InChI
Affinity DataKi:  3.16nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416289(CHEMBL1171787)copy SMILEScopy InChI
Affinity DataKi:  5.01nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416290(CHEMBL1171614)copy SMILEScopy InChI
Affinity DataKi:  7.94nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50359023(CHEMBL1170725)copy SMILEScopy InChI
Affinity DataKi:  10nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416307(CHEMBL1171011)copy SMILEScopy InChI
Affinity DataKi:  10nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416281(CHEMBL1169994)copy SMILEScopy InChI
Affinity DataKi:  12.6nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416306(CHEMBL1169995)copy SMILEScopy InChI
Affinity DataKi:  15.8nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416282(CHEMBL1170722)copy SMILEScopy InChI
Affinity DataKi:  19.9nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416294(CHEMBL1171760)copy SMILEScopy InChI
Affinity DataKi:  19.9nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416305(CHEMBL1169660)copy SMILEScopy InChI
Affinity DataKi:  25.1nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416286(CHEMBL1170801)copy SMILEScopy InChI
Affinity DataKi:  31.6nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416300(CHEMBL1171006)copy SMILEScopy InChI
Affinity DataKi:  31.6nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416298(CHEMBL1169653)copy SMILEScopy InChI
Affinity DataKi:  39.8nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416311(CHEMBL1171035)copy SMILEScopy InChI
Affinity DataKi:  50.1nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416309(CHEMBL1170800)copy SMILEScopy InChI
Affinity DataKi:  50.1nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416300(CHEMBL1171006)copy SMILEScopy InChI
Affinity DataKi:  63.1nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as inhibition of CCL2-induced chemotaxis in presence of 1% fetal bovine serumMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416295(CHEMBL1169652)copy SMILEScopy InChI
Affinity DataKi:  63.1nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416303(CHEMBL1170391)copy SMILEScopy InChI
Affinity DataKi:  126nMAssay Description:Antagonist activity at human CCR1 assessed as inhibition of MIP-1-alpha-induced [35S]-GTPgammaS binding after 3 to 4 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416300(CHEMBL1171006)copy SMILEScopy InChI
Affinity DataKi:  126nMAssay Description:Antagonist activity at human CCR1 assessed as inhibition of MIP-1-alpha-induced [35S]-GTPgammaS binding after 3 to 4 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416303(CHEMBL1170391)copy SMILEScopy InChI
Affinity DataKi:  126nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416291(CHEMBL1169824)copy SMILEScopy InChI
Affinity DataKi:  158nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416303(CHEMBL1170391)copy SMILEScopy InChI
Affinity DataKi:  158nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as inhibition of CCL2-induced chemotaxis in presence of 1% fetal bovine serumMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416294(CHEMBL1171760)copy SMILEScopy InChI
Affinity DataKi:  158nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416280(CHEMBL1170187)copy SMILEScopy InChI
Affinity DataKi:  200nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416300(CHEMBL1171006)copy SMILEScopy InChI
Affinity DataKi:  251nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416298(CHEMBL1169653)copy SMILEScopy InChI
Affinity DataKi:  251nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416301(CHEMBL1171758)copy SMILEScopy InChI
Affinity DataKi:  251nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416301(CHEMBL1171758)copy SMILEScopy InChI
Affinity DataKi:  316nMAssay Description:Antagonist activity at human CCR1 assessed as inhibition of MIP-1-alpha-induced [35S]-GTPgammaS binding after 3 to 4 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 4(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416304(CHEMBL1171786)copy SMILEScopy InChI
Affinity DataKi:  398nMAssay Description:Antagonist activity at CCR4More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416301(CHEMBL1171758)copy SMILEScopy InChI
Affinity DataKi:  398nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as inhibition of CCL2-induced chemotaxis in presence of 1% fetal bovine serumMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416293(CHEMBL1171938)copy SMILEScopy InChI
Affinity DataKi:  398nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416301(CHEMBL1171758)copy SMILEScopy InChI
Affinity DataKi:  398nMAssay Description:Antagonist activity at CCR2 in human THP1 cells assessed as inhibition of CCL2-induced chemotaxis in presence of 1% human serumMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416287(CHEMBL1170799)copy SMILEScopy InChI
Affinity DataKi:  398nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416288(CHEMBL1171788)copy SMILEScopy InChI
Affinity DataKi:  398nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 1(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416302(CHEMBL1171586)copy SMILEScopy InChI
Affinity DataKi:  501nMAssay Description:Antagonist activity at human CCR1 assessed as inhibition of MIP-1-alpha-induced [35S]-GTPgammaS binding after 3 to 4 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416293(CHEMBL1171938)copy SMILEScopy InChI
Affinity DataKi:  501nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416292(CHEMBL1171207)copy SMILEScopy InChI
Affinity DataKi:  631nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416292(CHEMBL1171207)copy SMILEScopy InChI
Affinity DataKi:  631nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416310(CHEMBL1171398)copy SMILEScopy InChI
Affinity DataKi:  794nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 4(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416285(CHEMBL1171008)copy SMILEScopy InChI
Affinity DataKi:  794nMAssay Description:Antagonist activity at CCR4More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416302(CHEMBL1171586)copy SMILEScopy InChI
Affinity DataKi:  794nMAssay Description:Antagonist activity at human CCR2 expressed in CHO cells assessed as inhibition of MCP1-induced [35S]-GTPgammaS binding after 3 hrsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416295(CHEMBL1169652)copy SMILEScopy InChI
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416303(CHEMBL1170391)copy SMILEScopy InChI
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 4(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50359023(CHEMBL1170725)copy SMILEScopy InChI
Affinity DataKi:  1.26E+3nMAssay Description:Antagonist activity at CCR4More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 4(Homo sapiens (Human))
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416305(CHEMBL1169660)copy SMILEScopy InChI
Affinity DataKi:  1.58E+3nMAssay Description:Antagonist activity at CCR4More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
TargetC-C chemokine receptor type 2(Mus musculus)
GlaxoSmithKline Medicines Research Centre

Curated by ChEMBL
LigandPNGBDBM50416302(CHEMBL1171586)copy SMILEScopy InChI
Affinity DataKi:  1.58E+3nMAssay Description:Antagonist activity at mouse CCR2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2B56KZ9PubMed
Displayed 1 to 50 (of 89 total ) | Next | Last >>
Jump to: